Harm Reduction Part Two: Strategies and Challenges for Tobacco and Nicotine Products
When: Oct. 28, 2021, 11:50 AM ET
Where: Virtual
Featuring:
- [Moderator] Barry S. Schaevitz, Partner, Fox Rothschild LLP
- Damon Jacobs, Associate Fellow, R Street Institute
- Mohamadi Sarkar, Fellow, Scientific Strategy and Advocacy, Altria Client Services
- Sheila P. Vakharia, Deputy Director, Department of Research and Academic Engagement, Drug Policy Alliance
Building off the preceding presentation, panelists will discuss harm reduction strategies with a focus on their specific applicability to tobacco and nicotine product usage. Topics will include: the challenges of harm reduction considering the lack of consensus on the harms posed by non-combustible nicotine products; the relative merit of restriction versus public education; and respective approaches stakeholders could apply to improve health outcomes
About the conference:
Join a diverse group of stakeholders – public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others – for this three-day conference on effectively regulating the broad spectrum of tobacco and nicotine products in the US. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.
